Table 3 Ongoing treatments at inclusion in the RESRIP network by disease (n = 406)
Total (n = 406) | JIAa (n = 255) | CTDb (n = 69) | AIDsc (n = 80) | Other (n = 57) | |
|---|---|---|---|---|---|
NSAIDsd | 209 (51.5) | 138 (67.3) | 18 (26.5) | 44 (54.3) | 9 (17.1) |
Joint infiltration | 40 (9.9) | 40 (19.5) | 0 (0) | 0 (0) | 0 (0) |
Biologic therapy | 117 (28.8) | 86 (41.9) | 3 (4.4) | 19 (23.5) | 9 (17.3) |
Colchicine | 41 (10.1) | 1 (0.5) | 2 (2.9) | 36 (44.4) | 2 (3.9) |
DMARDse | 157 (38.7) | 70 (34.2) | 45 (66.2) | 18 (22.2) | 24 (46.1) |
Glucocorticoids | 151 (37.2) | 51 (24.9) | 46 (67.6) | 28 (34.6) | 26 (50.0) |
Contraception | 9 (2.2) | 5 (2.4) | 2 (2.9) | 1 (1.2) | 1 (1.9) |
Homeopathy | 9 (2.2) | 5 (2.4) | 0 (0) | 2 (2.5) | 2 (3.8) |
Other treatmentf | 216 (53.2) | 98 (47.8) | 56 (82.3) | 35 (43.2) | 27 (51.9) |